Institut Kanser Negara
Putrajaya, Malaysia
4 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 3
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Non-small Cell Lung CancerAnaplastic Lymphoma Kinase-positive
Nuvalent Inc.450 enrolled157 locationsNCT06765109
Recruiting
Phase 1Phase 2
A Study of VRN110755 in Patients With EGFR-Mutant Non-Small Cell Lung Cancer
EGFR-mutant Non-small Cell Lung Cancer
Voronoi, Inc315 enrolled29 locationsNCT07699328
Recruiting
Phase 3
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Breast Cancer
Stemline Therapeutics, Inc.4,220 enrolled555 locationsNCT06492616
Recruiting
Phase 2Phase 3
INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC
Head and Neck Squamous Cell Carcinoma (HNSCC)
Inhibrx Biosciences, Inc410 enrolled88 locationsNCT06295731
Recruiting
Not Applicable
Perioperative Immunonutrition Under Enhanced Recovery After Surgery
Elective surgeryGynecological Cancer
Universiti Putra Malaysia106 enrolled1 locationNCT06039306
Recruiting
Not Applicable
The Effectiveness of E-health Intervention in Improving Mental Health Outcomes Among Breast Cancer Patients
Breast CancerBreast NeoplasmsDepression, Anxiety+1 more
National University of Malaysia114 enrolled1 locationNCT06566937